CD8A and pancreatic neoplasm: An additional study analyzing the quality of neoantigens reported that long-term survivors of pancreatic cancer compared to short-term survivors of pancreatic cancer have up to a 12-fold greater number of activated CD8+ T cells, which are proposed to target immunogenic neoantigens.